Forecast: Business Enterprise R&D Expenditure in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations in the UK

The forecast for Business Enterprise R&D Expenditure in the UK manufacturing sector of basic pharmaceutical products indicates a slight but consistent decline from 2024 to 2028. Starting at £446.5 million in 2024, it is projected to drop to £443.8 million by 2028. The year-on-year changes show a modest decrease each year, highlighting a trend of waning investment in R&D in this sector. In comparison to the pre-forecast year of 2023, where expenditure could have been higher, the sector is expected to experience a Compound Annual Growth Rate (CAGR) of negative growth over the next five years.

Potential trends to watch for include shifts in regulatory environments post-Brexit, technological advancements, and the impact of global economic conditions on R&D funding. These factors could alter the current forecast, presenting opportunities or further challenges in pharmaceutical innovation and expenditure.